4emv
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal structure of a topoisomerase ATP inhibitor== | ==Crystal structure of a topoisomerase ATP inhibitor== | ||
| - | <StructureSection load='4emv' size='340' side='right' caption='[[4emv]], [[Resolution|resolution]] 1.70Å' scene=''> | + | <StructureSection load='4emv' size='340' side='right'caption='[[4emv]], [[Resolution|resolution]] 1.70Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4emv]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4emv]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptococcus_pneumoniae_GA47373 Streptococcus pneumoniae GA47373]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EMV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4EMV FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0R9:5-{2-(ETHYLCARBAMOYL)-4-[3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-1H-PYRROLO[2,3-B]PYRIDIN-5-YL}PYRIDINE-3-CARBOXYLIC+ACID'>0R9</scene> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0R9:5-{2-(ETHYLCARBAMOYL)-4-[3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-1H-PYRROLO[2,3-B]PYRIDIN-5-YL}PYRIDINE-3-CARBOXYLIC+ACID'>0R9</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4emv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4emv OCA], [https://pdbe.org/4emv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4emv RCSB], [https://www.ebi.ac.uk/pdbsum/4emv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4emv ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 20: | Line 18: | ||
==See Also== | ==See Also== | ||
| - | *[[Topoisomerase|Topoisomerase]] | + | *[[Topoisomerase 3D structures|Topoisomerase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Streptococcus pneumoniae | + | [[Category: Large Structures]] |
| - | [[Category: Boriack-Sjodin | + | [[Category: Streptococcus pneumoniae GA47373]] |
| - | [[Category: Hull | + | [[Category: Boriack-Sjodin PA]] |
| - | [[Category: Manchester | + | [[Category: Hull K]] |
| - | + | [[Category: Manchester J]] | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 07:18, 28 September 2022
Crystal structure of a topoisomerase ATP inhibitor
| |||||||||||
